Rare diseases
Investigational molecules
Locations
Back to Bulgaria31 clinical trials in Gorna Oryahovitsa, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
BulgariaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BulgariaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
BulgariaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
BulgariaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
BulgariaStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
BulgariaStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
BulgariaA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
BulgariaSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
BulgariaA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on uncontrolled asthma management and innovative treatments to improve respiratory function. Research includes evaluation of novel antibody therapies and their effects on exhaled biomarkers.
Groundbreaking trials investigating treatments for atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new therapies for reducing major adverse cardiovascular events and improving patient outcomes.
Comprehensive research into inflammatory bowel conditions, including Crohn's disease and ulcerative colitis. Studies focus on developing new therapeutic approaches for moderate to severe disease states.
Vital research addressing COVID-19 and C. difficile infections. Studies include pediatric treatments and prevention strategies for recurring infections.
Advanced studies on metabolic dysfunction-associated steatohepatitis and liver conditions. Research focuses on innovative treatments for fibrosis regression and improving liver health outcomes.
Innovative research targeting neovascular age-related macular degeneration. Studies compare treatment efficacy and visual acuity improvements in patients with retinal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
